Clinical Trial Update: Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating tailoring P2Y12 inhibitor therapy for patients with coronary artery disease requiring oral anticoagulation after PCI; results ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: University of Florida | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2025-07-31